CRYPTOCOCCUS NEOFORMANS ANTISERUM, LATEX— 510(k) K792693

Substantially Equivalent

Meridian Diagnostics, Inc.

FDA 510(k) clearance K792693 for CRYPTOCOCCUS NEOFORMANS ANTISERUM, LATEX, Substantially Equivalent on 1980-01-21. Applicant: Meridian Diagnostics, Inc..

Clearance details

Applicant
Meridian Diagnostics, Inc.
Product code
Code GMD
Advisory panel
Microbiology
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Traditional
Location
Mchenry, IL, US
Download summary PDFView on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.